Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Neurophysiologie Clinique = Clinical Neurophysiology|September 30, 2020
Utility of nerve ultrasound in ulnar neuropathy with abnormal non-localizing electrophysiology in diabetes mellitusLuciana Pelosi, Vivien Yong, Lance D BlumhardtMultiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four yearsBenjamin Turner, Xia Lin, Guillaume Calmon, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosisJanek Vilisaar, Martin Wilson, Graham Niepel, et al.Journal of the Neurological Sciences|May 9, 2002
White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosisLalitha Vaithianathar, Chris R Tench, Paul S Morgan, et al.Journal of Neurology|September 21, 2002
T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imagingLalitha Vaithianathar, Chris R Tench, Paul S Morgan, et al.Therapeutics and Clinical Risk Management|April 28, 2010
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosisKenneth P JohnsonThe Neurologist|July 12, 2007
Natalizumab (Tysabri) treatment for relapsing multiple sclerosisKenneth P JohnsonExpert Review of Neurotherapeutics|March 28, 2012
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosisKenneth P JohnsonExpert Opinion on Drug Metabolism & Toxicology|April 20, 2010
Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an updateKenneth P JohnsonJournal of the Neurological Sciences|March 14, 2007
Control of multiple sclerosis relapses with immunomodulating agentsKenneth P JohnsonPageof 3